CC2018: The Difficult Gallbladder: Staying Out of Trouble
All surgeons doing cholecystectomy frequently encounter the patient with a terribly inflamed, thickened gallbladder where delineation of the normal anatomical structures is difficult or even impossible. How do we manage these cases safely?
- The Difficult Gall Bladder: Setting the Stage and General Principles
David C. Borgstrom, MD, MBA, FACS, Morgantown, WV
- 2018 Tokyo Guidelines for the Diagnosis and Management of Acute Cholecystitis: Pros and Cons
Abe L. Fingerhut, MD, FACS, Graz, Austria
- What Is the Difficult Gallbladder?
Andrew B. Peitzman, MD, FACS, Pittsburgh, PA
- What to Do When the Critical View of Safety Cannot Be Reached?
Randall S. Zuckerman, MD, FACS, Kalispell, MT
- What Is the Role of Percutaneous Cholecystostomy Drainage?
L. Michael Brunt, MD, FACS, St Louis, MO
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
- For questions about the course content, please contact email@example.com.
- If you have any technical questions, contact firstname.lastname@example.org.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position
to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all
relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website:
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational
activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to
identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias
during a activity, please report it on the evaluation.
(Download the full list of disclosures.)
Faculty and Disclosures
David C. Borgstrom, MD, MBA, FACS, Morgantown, WV - No Disclosures
Abe L. Fingerhut, MD, FACS, Graz, Austria - No Disclosures
Andrew B. Peitzman, MD, FACS, Pittsburgh, PA - No Disclosures
Randall S. Zuckerman, MD, FACS, Kalispell, MT - No Disclosures
L. Michael Brunt, MD, FACS, St. Louis, MO - Gore, Karl Storz: Institutional research support
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - No Disclosures
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - No Disclosures
David C. Borgstrom, MD, FACS, Morgantown, WV - No Disclosures
Daniel L. Dent, MD, FACS, San Antonio, TX - No Disclosures
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Audra A. Duncan, MD, FACS, London, ON - No Disclosures
Mariam F. Eskander, MD, Boston, MA - No Disclosures
Paula Ferrada, MD, FACS, Richmond, VA - No Disclosures
Neil H. Hyman, MD, FACS, Chicago, IL - No Disclosures
Martin S. Karpeh, Jr., MD, FACS, New York, NY - No Disclosures
Dennis H. Kraus, MD, FACS, New York, NY - No Disclosures
Kenneth W. Sharp, MD, FACS, Nashville, TN - No Disclosures
David A. Spain, MD, FACS, Stanford, CA - No Disclosures
Mary T. Hawn, MD, FACS, Stanford, CA - No Disclosures
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - No Disclosures
Barbara Lee Bass, MD, FACS, FRCS(Hon), Houston, TX - No Disclosures
Quan-Yang Duh, MD, FACS, San Francisco, CA - No Disclosures
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - No Disclosures
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - No Disclosures
Valerie W. Rusch, MD, FACS, New York, NY - No Disclosures
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit